Jason Alger, Chief Financial Officer at Health Catalyst, Inc. (HCAT), sold 39,198 shares at $8.32 ($326K) on 2024-12-06, disclosed to the SEC on 2024-12-10.
Scheduled sale ($326k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.32 | 19,599 | $163K | 50.0% |
| 2 | $8.32 | 19,599 | $163K | 50.0% |
| Total | $8.32 avg | 39,198 | $326K | 100% |
| Filing → |
| HCAT | SELL | 2023-12-07 | $16K | — | Filing → |
| HCAT | SELL | 2023-09-06 | $26K | — | Filing → |
| HCAT | SELL | 2023-06-08 | $28K | — | Filing → |